Reaction profile

The FDA adverse-event record for agalactia

20 FDA reports name agalactia, a lower-volume reaction in the CVM extract (VeDDRA 531). Plate stamps and neighbourhood peers follow.

#2155 of 2,481
by report volume (all reactions)
20
reports citing this reaction
30.0%
death-coded share
Dog
most-affected species
Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Agalactia has 20 reports now versus 20 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Agalactia changes

FDA AER · VeDDRA plate

Code 531 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 20 reports
  • DEATH-HOT 30.0%
  • LOWER-Q #2155/2481
  • PHOTO-FINISH Application site pigm…
  • SPECIES-DOG Dog · 8
  • DRUG-LEAD Monensin Sodium · 4
  • DESK-WIDE 12 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Application site pigmentation disorders (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Agalactia

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Agalactia · this reaction20Application site pigm… · near20Application site skin… · near20Cirrhosis · near20Clonic muscle spasm · near20Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Agalactia

Agalactia: high death-coded share in the FDA AER plate

Signature read: 20 reports place Agalactia in the lower third of FDA AER volume (#2155 of 2,481). Report volume is lower-third scale: 20 named reports in the openFDA extract. Death-coded share is upper-third: 6 of 20 reports (30.0% of named reports). Nearest volume peer: Application site pigmentation disorders (±0 reports). Lead species Dog (8). Lead co-reported drug Monensin Sodium (4).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 8
Cattle 6
Goat 5
Horse 1

Breeds Most Affected

Holstein-Friesian also known as Holstein 4
Boer 4
Spitz - German Pomeranian 3
Crossbred Caprine/goat 1
Collie - Smooth-haired 1
Quarter Horse 1
Cattle (unknown) 1
Bulldog - French 1
Crossbred Canine/dog 1
Pekingese 1

Associated Drugs

Monensin Sodium 4
Spinosad 3
Ivermectin 3
Sometribove 3
Selamectin 2
Ceftiofur 1
Ceftiofur Hydrochloride 1
Milbemycin Oxime + Spinosad 1
Pergolide Mesylate 1
Cephapirin Benzathine 1
Amoxicillin Trihydrate, Clavulanate Potassium 1
Anesthetics 1
Fluralaner Chew Tablets 1
Moxidectin 1
Ibr, Bvd Cp Type1, Ncp Type 1 And 2, Pi3, Brsv, Killed Virus, C Fetus- L Canicola-Grippo-Hardjob-Icteroh-Pomona, Bacterin 1
Coumaphos + Diazinon 1
Autogenous Pinkeye Vaccine 1
Calcium 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Agalactia (#2155 of 2,481 by report volume); death-coded 30.0%. PlainBreed reaction plate · report volume stamp 20 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →